Japan High Court Blocks National Insurance Coverage For Drugs, Devices Unapproved Domestically
This article was originally published in PharmAsia News
Executive Summary
TOKYO - A Japanese high court Sept. 29 banned so-called "mixed treatment and billing," using Japan's National Health Insurance coverage and patients' out-of-pocket payments, for pharmaceuticals and medical devices approved in other countries but not in Japan